| Date | Time | Source | Headline | Symbol | Company |
| 08/09/2012 | 7:24AM | Dow Jones News | AstraZeneca: Bristol-Myers Squibb Completes Purchase of Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 3:11PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 8:19AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2012 | 7:40AM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/03/2012 | 3:26PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 5:03PM | Dow Jones News | 2nd UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 1:00PM | Dow Jones News | UPDATE: Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 11:30AM | Dow Jones News | Bristol-Myers Executive Charged With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 11:17AM | Dow Jones News | U.S. Charges Bristol-Myers Executive With Insider Trading | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/02/2012 | 10:07AM | Dow Jones News | Bristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 7:15AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 6:49AM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/01/2012 | 6:30AM | Business Wire | Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/31/2012 | 12:32PM | Zacks | Solid Quarter at ALKS, View Backed - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/30/2012 | 3:23PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/27/2012 | 4:22PM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/27/2012 | 4:13PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/27/2012 | 4:10PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 7:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/26/2012 | 9:24AM | Dow Jones News | Evercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking Revenue | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/25/2012 | 7:20AM | Dow Jones News | Bristol-Myers Profit Falls 28% | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/25/2012 | 7:00AM | Dow Jones News | Bristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent Expirations | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/25/2012 | 4:39AM | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/25/2012 | 4:39AM | Zacks | Generic Plavix Hurts Bristol-Myers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |